UHS (Universal Health Services, Inc. Class B) Stock Analysis - Hedge Fund Holdings

Universal Health Services, Inc. Class B (UHS) is a publicly traded Healthcare sector company. As of May 21, 2026, UHS trades at $165.30 with a market cap of $10.25B and a P/E ratio of 6.82. UHS moved -1.22% today. Year to date, UHS is -26.27%; over the trailing twelve months it is -16.05%. Its 52-week range spans $152.33 to $246.33. Analyst consensus is buy with an average price target of $225.92. Rallies surfaces UHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns UHS stock?

Hedge funds tracked by Rallies that own UHS include Glenview Capital, Orbimed Advisors, Bridgewater Associates, Panagora Asset, and Pinebridge Investments. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Universal Health Services, Inc. Class B.

UHS Key Metrics

Key financial metrics for UHS
MetricValue
Price$165.30
Market Cap$10.25B
P/E Ratio6.82
EPS$24.27
Dividend Yield0.20%
52-Week High$246.33
52-Week Low$152.33
Volume1
Avg Volume0
Revenue (TTM)$17.76B
Net Income$1.55B
Gross Margin0.00%

Top Hedge Funds Holding UHS

  • Glenview Capital holds 482.17K shares of UHS, changed +23.80% as of Sep 30, 2025.
  • Orbimed Advisors holds 269.30K shares of UHS, changed +72.63% as of Dec 31, 2024.
  • Bridgewater Associates holds 136.37K shares of UHS, changed -38.02% as of Mar 31, 2026.
  • Panagora Asset holds 131.11K shares of UHS, changed +1603.82% as of Mar 31, 2026.
  • Pinebridge Investments holds 25.85K shares of UHS, changed -77.60% as of Sep 30, 2025.

Latest UHS News

Recent UHS Insider Trades

  • SUSSMAN ELLIOT J MD MBA sold 356 (~$68.84K) on Mar 13, 2026.
  • SUSSMAN ELLIOT J MD MBA sold 318 (~$59.26K) on Mar 11, 2026.
  • Nimetz Warren J. sold 3.67K (~$820.54K) on Nov 11, 2025.

UHS Analyst Consensus

13 analysts cover UHS: 0 strong buy, 5 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $225.92.

Common questions about UHS

Who owns UHS stock?
Hedge funds tracked by Rallies that own UHS include Glenview Capital, Orbimed Advisors, Bridgewater Associates, Panagora Asset, and Pinebridge Investments. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Universal Health Services, Inc. Class B.
Does Rallies show 13F holders for UHS?
Yes. Rallies tracks hedge fund and 13F ownership data for UHS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is UHS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UHS. It does not provide personalized investment advice.
UHS

UHS